• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 SORBAFIX ENHANCED; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 SORBAFIX ENHANCED; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number 0113115
Medical Device Problem Code Unintended Ejection (1234)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2025
Type of Reportable Event Malfunction
Event or Problem Description
As reported, during tapp procedure using sorbafix fixation device, two fasteners were deployed at once.It was also reported that initial three fasteners were fixated successfully and the fixation was carried out in rectus abdominis muscle, bilateral inferior epigastric artery/vein, near the pubic bone.The fastener was removed from the patient's body and another device was used to complete the procedure.There was no patient injury.
 
Additional Manufacturer Narrative
As reported, during tapp procedure using sorbafix fixation device, two fasteners were deployed at once.Evaluation of the returned sample could not reproduce the reported event.The device functioned as intended during functional and simulated use testing, deploying the last remaining fasteners with no issues.No manufacturing anomalies found.Review of manufacturing records shows product was made to specification.To date, this is the only reported complaint for this manufacturing lot of (b)(4) units.The instructions-for-use supplied with the device adequately describe the proper technique for fastener delivery.The contradictions section states, " carefully inspect the area in the vicinity of the tissue being fastened to avoid inadvertent penetration of underlying structures such as nerves, vessels, viscera, or bone.Use of the sorbafix absorbable fixation system in the close vicinity of such underlying structures is contraindicated." note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SORBAFIX ENHANCED
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key23838932
Report Number1213643-2025-01243
Device Sequence Number9958822
Product Code GDW
UDI-Device Identifier00801741016691
UDI-Public(01)00801741016691(11)250303(17)270228(10)HUKP1360
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K111153
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number0113115
Device Lot NumberHUKP1360
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/02/2025
Initial Report FDA Received Date12/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/03/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-